Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
about
Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stabilityParkin Regulation and Neurodegenerative DisordersThe effects of oxidative stress on parkin and other E3 ligases.The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease.Human gene therapy and imaging in neurological diseases.Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype.Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutationsAlternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain.Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson's diseaseHSPA1A-independent suppression of PARK2 C289G protein aggregation by human small heat shock proteinsOlfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.The genetic basis of Parkinson's diseaseDopamine agonists and neuroprotection in Parkinson's disease.The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD studyCompensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele.Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin.PINK1 mutation heterozygosity and the risk of Parkinson's disease.Parkinson's disease: the genetics of a heterogeneous disorder.Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.Molecular imaging in hereditary forms of parkinsonism.Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease.A multidisciplinary study of patients with early-onset PD with and without parkin mutations.Parkinson's disease: from genetics to clinical practice.Versatile members of the DNAJ family show Hsp70 dependent anti-aggregation activity on RING1 mutant parkin C289G.PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity.Syndromic approach to Parkinson's disease: role of functional imaging.Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.The genetic architecture of mitochondrial dysfunction in Parkinson's disease.Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.Neuroimaging in Parkinson's disease
P2860
Q24299939-9620F623-C3A9-4C7F-8B15-E576D7B00CB7Q26770443-262EBEDF-C354-4582-A1F3-9BC5081748D9Q30273796-0E5EC8AE-AB18-4C5A-BEC5-84C1AA0662CDQ30886687-674B9DAD-BF20-4C32-BE74-1094B9E64ED0Q31023442-96AF765F-CD83-4DA7-A2DA-DAA1CAD3CFE6Q33275606-9331D86C-C1D9-4240-88D3-B3DD565EDC3EQ33577056-F44E4D6C-435A-4F00-836A-77D8BF43BCD3Q33652645-5EA1506F-492F-4B1A-A883-9B7679BC7AD6Q33771544-47F8C391-2239-4E66-93F1-BC25CA161ADCQ34014415-2EC9CD7D-0171-49D6-B10F-59540BF21F82Q34215600-8E2F51A2-9AE7-42EE-BEE4-570AE64A5C94Q34298044-D0F9386C-06D6-4851-BC62-48EA3C8FB90CQ34555482-7B7E89CE-C6FF-4C00-94B8-5F6A29F877B5Q34863976-7D635D40-0A6F-4318-9264-9E963A048E64Q35015790-01AFDB72-0619-4161-B52A-696B0A36D8C3Q35054613-CB50CC83-F4E8-4181-8DA8-83BAC7D4F806Q35888655-40F4F857-6EB9-4A3F-A038-5E9280BBF327Q35898027-5C1173D3-F60C-4E80-B399-E621181DB53BQ36223221-1BB7952A-830B-44C0-AB25-C8BD669BEDFAQ36227281-E1C5B7BD-79FB-4A9B-A3D4-8B6811DDB3F1Q36516918-6C756524-986E-48F5-B240-EEC1941CA187Q36761674-8CD73DE3-F558-4AD3-B4A0-221C2CDB7189Q36771898-3140E6BD-4143-409E-B98B-C1CEE1ED77E4Q37151410-CDF93C5D-A593-4CF7-B724-0EE4647E4663Q37180446-5F2D71B9-1BCD-4380-8FE6-8E7B6BEF94CFQ38188556-A467BD7A-549D-4843-B191-B7D62488B2B6Q39314887-446E715D-6811-4865-8E8F-0AE514F45D99Q39647087-0C5E76F3-5502-47EB-B42C-157036B16990Q41979984-C032E8A2-9EBC-41A7-9F6C-2A0BF7CBA2EAQ42696784-D9564DCD-4F46-4F4B-8416-624F584AF480Q43086923-CDB2DE05-E206-4477-81A6-AC3E3B8E8F49Q47646796-FF0B3100-AABE-45B0-AC1B-1B7ED57C4FA1Q50543611-64814458-592F-49F2-982C-1468956B2514Q57088961-9B75D25A-B753-4E58-81F1-E90B7346B896
P2860
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Positron emission tomographic ...... mutations in the parkin gene.
@en
Positron emission tomographic ...... mutations in the parkin gene.
@nl
type
label
Positron emission tomographic ...... mutations in the parkin gene.
@en
Positron emission tomographic ...... mutations in the parkin gene.
@nl
prefLabel
Positron emission tomographic ...... mutations in the parkin gene.
@en
Positron emission tomographic ...... mutations in the parkin gene.
@nl
P2093
P356
P1433
P1476
Positron emission tomographic ...... mutations in the parkin gene.
@en
P2093
Ozelius LJ
Pramstaller PP
Strotmann T
P304
P356
10.1002/ANA.74.ABS
P577
2001-03-01T00:00:00Z